EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
As announced in the last EU Monitor, the European Association of Hospital Pharmacists (EAHP) has teamed up with Affordable Medicines Europe, the European Public Health Alliance (EPHA), the European Healthcare Distribution Association (GIRP) and the Pharmaceutical Group of the European Union (PGEU) to organise a series of webinars focusing on solutions to mitigate the impact of medicines shortages in Europe. The second webinar zooming in on prevention, response plans and risk assessments will be hosted by EAHP on 27 October 2020 at 4 PM CET.
Prevention is one solution that can help to alleviate the growing problems caused by medicine shortages for patients all over Europe. The second webinar of the series, “Zooming in on Solutions,” will look at two types of prevention strategies. For healthcare institutions, it is important to assess the critical need for a medicine when there are shortages and its ability to continue to provide patient care. With the help of so-called ‘prospective risk assessments,’ healthcare institutions can better predict emerging risks from shortages and prevent them from occurring. However, despite the potential of prospective risk assessments, their uptake is slow, in particular since data, knowledge and skills on how to apply risk assessments in everyday practice are lacking. Another type of prevention strategy—prevention and response plans—has been pioneered by France since 2016. This tool targets in particular producers and encourages them to establish shortage management plans.
This webinar will explore the potential of both prevention & response plans and prospective risk assessments. Join us on 27thOctober at 4 PM CET to learn more!
Register via the following LINK
Learn more about the webinar HERE
At the beginning of October, the member organisations of the European Association of Hospital Pharmacists (EAHP) adopted a new position paper on pharmacy preparations and compounding. The position aims at providing information about the practice of pharmacy preparations and compounding in hospitals and asks for a stronger embedment of compounding and reconstitution practices in European hospital pharmacies, linked to increasing capacity and training.
The different sections of EAHP’s position paper touch on the importance of compounding for addressing patient needs, the involvement of hospital pharmacies in reconstitution practices and the role of hospital pharmacists in the preparation and use of advanced therapy medicinal products (ATMPs). Linked to personalised medication, it shares information on the engagement of hospital pharmacists and the adjustments that should be realised in education and training to comply with the increased need for personalised care. To further enhance patient care in Europe, EAHP
Read EAHP’s Position Paper on Pharmacy Preparations and Compounding HERE
On 29 October at 7 PM CET, EAHP and the European Society of Clinical Pharmacy (ESCP) will be holding a webinar to share selected inspiring examples of clinical and hospital pharmacy services for COVID-19 patients as well as a clinical update and the results of the qualitative study of ESCP on the impact of the COVID-19 pandemic on clinical pharmacy practice.
Learn from the experience of your colleagues working at the Hospital AZ Sint-Lucas in Gent (Belgium), the Fatebenefratelli-Sacco Hospital in Milan (Italy) and the COVID Medication Coordination Centre (LCG) in the Netherlands. After the webinar, you should be able to give an overview on the possible (preventive) pharmacological therapy options for COVID-19 and their effectiveness and to share information on the impact that the COVID-19 pandemic has on clinical pharmacy practice.
Join us on 29th October by registering via the following LINK!
Learn more about the ESCP webinar series HERE
On 22 October, the European Medicines Agency (EMA) will be celebrating its 25th anniversary with a virtual conference focusing on building, learning and adapting to new challenges. The conference will be broadcasted between 2.00 and 4.30 PM CEST on EMA’s website. The event aims at addressing the key achievements and learnings from recent years as well as to elaborate further on key strategic areas looking forward, amid the current challenges.
Access the agenda HERE
Watch the broadcast HERE
A member of the German Society of Hospital Pharmacists has put together a survey in order to demonstrate the benefits of a ward pharmacist in oncology and thus help to increase the patient’s therapeutic safety.
To assess the impact of possible improvements and to get the most comprehensive picture possible, it is necessary to determine the current situation throughout Europe. For representative data collection, only one answer from each hospital pharmacy is allowed. Your information will be handled strictly confidential and the results will only be published anonymously. Responses can be shared until 15 December 2020. Participation only takes a few minutes and aims also at supporting pharmacists in clinics without a cytostatics department.
Access the survey via the following LINK
The original research published in the online edition of the European Journal of Hospital Pharmacy (EJHP) aims to assess the effectiveness of the clinical pharmacist approach to refining disease-specific knowledge in patients with chronic obstructive pulmonary disease (COPD) treated in a tertiary care hospital. The authors carried out a prospective observational longitudinal study in adult COPD patients for 9 months in the tertiary care hospital of Pune. Based on their findings they concluded that the knowledge of patients with COPD about the disease and its treatment was poor at the time of enrolment and that proper counselling and education provided by the clinical pharmacist helped to improve the patients’ knowledge about COPD and its treatment.
Read the article HERE
[COVID-19 Updates]
EAHP’s COVID-19 Resource Centre
To assist its member associations and individual hospital pharmacists in this critical time with the provision of the best possible care for patients, EAHP has decided to gather and make available information on COVID-19 relevant for the hospital pharmacy profession.
Access the Resource Centre HERE
French Society of Anaesthesia & Intensive Care Medicine (SFAR) – COVID-19 Hub | Informations générales sur COVID-19
SFARs COVID-19 hub contains the latest information for practitioners. The available information is in French.
Access the hub HERE
Journal of Oncology Pharmacy Practice – Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety
The article highlights challenges related to safe handling of hazardous drugs and maintaining high-quality medication safety standards that have impacted various stakeholders.
Access the article HERE
EAHP has developed a series of videos for the different sections of the European Statements of Hospital Pharmacy to help you better understand how hospital pharmacists should be involved in the delivery of hospital pharmacy services. Watch them here!
___________________________________________________________________________________
Consultations
EMA – Guideline on registry-based studies
The guideline was developed based on the comments received on the discussion paper on ‘Methodological and operational considerations on the use of patient disease registries for regulatory purposes’, that went through a public consultation between November 2018 and June 2019, and a consultation of EMA Committees and Working parties.
Deadline – 31st December 2020
Access the consultation HERE
EDQM – Pharmeuropa PaedForm, Issue 2
The EDQM has just released issue 2 of Pharmeuropa PaedForm, in which the third monograph elaborated by the PaedForm Working Party, the draft text for an ethanol-free formulation for Furosemide 2 mg/mL Oral Solution, is published for public consultation prior to its inclusion in the European Paediatric Formulary.
Deadline – 31st December 2020
Find more information HERE
